Tevogen (TVGN) EPS (Basic) (2022 - 2026)
Tevogen's (TVGN) quarterly EPS (Basic) came in at -$1.52 in Q2 2026, down 4882.5% on a YoY basis from $0.03 in Q2 2025, and up 5.42% quarter-over-quarter from -$1.61 in Q1 2026.
Analysis
Tevogen (TVGN) EPS (Basic) (2022 - 2026) Analysis & Trends
Tevogen (TVGN) has reported EPS (Basic) for 5 consecutive years, with -$1.52 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) fell 4882.5% year-over-year to -$1.52; the trailing twelve-month figure through Jun 2026 stood at -$5.78 (down 3286.92% YoY), and the FY2025 full-year result was -$8.08, down 11436.0% from the prior year.
- EPS (Basic) grew to -$1.52 in Q2 2026 per TVGN's latest filing, from -$1.61 in the prior quarter.
- Across five years, EPS (Basic) topped out at $2.29 in Q4 2023 and bottomed at -$1.61 in Q1 2026.
- Historically, EPS (Basic) has averaged -$0.15 across 5 years, with a median of -$0.03 in 2025.
- The sharpest annual moves came in 2023 and 2026: EPS (Basic) surged 8252.65% in 2023, then tumbled 4882.5% in 2026.
- Over 5 years, EPS (Basic) stood at $0.05 in 2022, then surged by 4414.26% to $2.29 in 2023, then tumbled by 102.8% to -$0.06 in 2024, then sank by 2162.17% to -$1.45 in 2025, then dropped by 5.09% to -$1.52 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$1.52, -$1.61, and -$1.45 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | 1.85 |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - | -0.94 |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn | -0.11 |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 0.42 |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | -1.22 |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | -1.18 |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | 0.06 |
| 8 | Sarepta Therapeutics | 2.14 Bn | 1.35 Bn | 251.87 Mn | -0.05 |
| 9 | Vericel | 1.93 Bn | 1.76 Bn | 56.40 Mn | 0.04 |
| 10 | Tevogen | 26.95 Mn | 26.95 Mn | - | -1.52 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.52 |
| Mar 31, 2026 | -1.61 |
| Dec 31, 2025 | -1.45 |
| Sep 30, 2025 | -0.03 |
| Jun 30, 2025 | -0.03 |
| Mar 31, 2025 | -0.07 |
| Dec 31, 2024 | -0.06 |
| Sep 30, 2024 | -0.03 |
| Jun 30, 2024 | -0.04 |
| Mar 31, 2024 | 0.08 |
| Dec 31, 2023 | 2.29 |
| Sep 30, 2023 | -0.25 |
| Jun 30, 2023 | -0.01 |
| Mar 31, 2023 | 0.04 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |